Literature DB >> 6221545

In vitro and in vivo effects of new powerful thromboxane antagonists (3-alkylamino pinane derivatives).

M Katsura, T Miyamoto, N Hamanaka, K Kondo, T Terada, Y Ohgaki, A Kawasaki, M Tsuboshima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6221545

Source DB:  PubMed          Journal:  Adv Prostaglandin Thromboxane Leukot Res        ISSN： 0732-8141


× No keyword cloud information.
  10 in total

1.  Effect of intracisternal thromboxane A2 analogue on cerebral artery permeability.

Authors:  M Zuccarello; T Sasaki; N F Kassell; M Yamashita
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

2.  Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.

Authors:  A H Krauss; D F Woodward; L L Gibson; C E Protzman; L S Williams; R M Burk; T S Gac; M B Roof; F Abbas; K Marshall; J Senior
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

3.  Involvement of thromboxane and leukotriene in arachidonate induced coronary constriction in diabetic rats.

Authors:  Y Takiguchi; K Umemura; H Hashimoto; M Nakashima
Journal:  Diabetologia       Date:  1989-06       Impact factor: 10.122

4.  Thromboxane A2, released by the anti-tumour drug irinotecan, is a novel stimulator of Cl- secretion in isolated rat colon.

Authors:  H Sakai; T Sato; N Hamada; M Yasue; A Ikari; B Kakinoki; N Takeguchi
Journal:  J Physiol       Date:  1997-11-15       Impact factor: 5.182

5.  Evidence for thromboxane receptor mediated contraction of guinea-pig and human airways in vitro by prostaglandin (PG) D2, 9 alpha,11 beta-PGF2 and PGF2 alpha.

Authors:  R L Featherstone; C Robinson; S T Holgate; M K Church
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-05       Impact factor: 3.000

Review 6.  Prostanoid receptor antagonists: development strategies and therapeutic applications.

Authors:  R L Jones; M A Giembycz; D F Woodward
Journal:  Br J Pharmacol       Date:  2009-07-15       Impact factor: 8.739

7.  Binding of a radioiodinated 13-azapinane thromboxane antagonist to platelets: correlation with antiaggregatory activity in different species.

Authors:  S Narumiya; M Okuma; F Ushikubi
Journal:  Br J Pharmacol       Date:  1986-06       Impact factor: 8.739

8.  Actions of the novel thromboxane A2 antagonists, ONO-1270 and ONO-3708, on smooth muscle cells of the guinea-pig basilar artery.

Authors:  M Fujioka; T Nagao; H Kuriyama
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-12       Impact factor: 3.000

9.  Difluorothromboxane A2 and stereoisomers: stable derivatives of thromboxane A2 with differential effects on platelets and blood vessels.

Authors:  T A Morinelli; A K Okwu; D E Mais; P V Halushka; V John; C K Chen; J Fried
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

10.  Thromboxane A2 receptor is highly expressed in mouse immature thymocytes and mediates DNA fragmentation and apoptosis.

Authors:  F Ushikubi; Y Aiba; K Nakamura; T Namba; M Hirata; O Mazda; Y Katsura; S Narumiya
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.